Clinic-Biological Features and Prognostic Significance of MGUS-Like Myeloma who underwent to Autologous Stem Cell Transplantation

The MGUS-like profile is a baseline-evaluable feature that identifies a subset of patients with distinct clinical behavior and may predict greater benefit from high-dose melphalan, due to the high rate of CR MRD-ve resulting in longer survival.

Authors

Institutions

Publication Details

Journal
Clinical Lymphoma Myeloma & Leukemia
Published
2025-11-21
DOI
https://doi.org/10.1016/j.clml.2025.11.007
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinic-Biological Features and Prognostic Significance of MGUS-Like Myeloma who underwent to Autologous Stem Cell Transplantation

Rafael López‐López, Irène Bueno, Jose Juan Perez-Moran, Beatriz Rey-Búa et al.
Clinical Lymphoma Myeloma & Leukemia
Multiple Myeloma Research and Treatments
article

Clinic-Biological Features and Prognostic Significance of MGUS-Like Myeloma who underwent to Autologous Stem Cell Transplantation

Rafael López‐López, Irène Bueno, Jose Juan Perez-Moran, Beatriz Rey-Búa, Abelardo Bárez, Fernando Escalante, Verónica González‐Calle, Carlos Aguilar-Franco, Noemí Puig, Norma Carmen Gutierrez, Lucía López‐Corral, Borja Puertas, Julio Dávila, Alfonso García de Coca, José María Alonso-Alonso, María‐Belén Vídriales, Juan Flores‐Montero, Elena Alejo, Fe Serra-Toral, Maria-Victoria Mateos, Aránzazu García‐Mateo, Roberto Sosa Hernández, Alberto Cantalapiedra-Diez
article en

Abstract

The MGUS-like profile is a baseline-evaluable feature that identifies a subset of patients with distinct clinical behavior and may predict greater benefit from high-dose melphalan, due to the high rate of CR MRD-ve resulting in longer survival.

Clinical Lymphoma Myeloma & LeukemiaVol. 26(2)
Universidad de Valladolid (ES), Soran University (IQ), Hospital General De Segovia (ES), Hospital Rio Carrion (ES), Centro de Investigación Biomédica en Red (ES), Hospital Universitario de Burgos (ES), Hospital Virgen de la Concha (ES), Instituto de Investigación Biomédica de Salamanca (ES), Centro de Investigación del Cáncer (ES), Hospital Universitario Río Hortega (ES), Hospital Universitario de León (ES), Hospital Virgen del Puerto (ES), Hospital Nuestra Señora de Alarcos (ES), Universidad de Burgos (ES)
Amgen, Sanofi, Alexion Pharmaceuticals, Celgene, Prothena, Aptitude Health
Openalex Percentile: Top 54%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.